![](/img/cover-not-exists.png)
The RB–IL-6 axis controls self-renewal and endocrine therapy resistance by fine-tuning mitochondrial activity
Kitajima, S, Yoshida, A, Kohno, S, Li, F, Suzuki, S, Nagatani, N, Nishimoto, Y, Sasaki, N, Muranaka, H, Wan, Y, Thai, T C, Okahashi, N, Matsuda, F, Shimizu, H, Nishiuchi, T, Suzuki, Y, Tominaga, K, GoLanguage:
english
Journal:
Oncogene
DOI:
10.1038/onc.2017.124
Date:
May, 2017
File:
PDF, 3.44 MB
english, 2017